Ivermectin reduces withdrawal-induced alcohol intake in rats: Association with CeA GABAergic enhancement and P2rx4 genotype (2026)

Peer-Reviewed Study · Campo P, Qiao R, Doyle MR, Munro D, et al. · 2026

Campo P et al., 2026: 2026 rat study in heterogeneous stock rats showing ivermectin reduced alcohol intake during acute withdrawal, with the effect tied to P2rx4 expression and GABAergic signalling in the central amygdala.

These findings suggest that P2rx4 upregulation serves as a vulnerability marker for dependence-like behaviors, with ivermectin attenuating withdrawal-driven alcohol consumption by enhancing CeA GABAergic inhibition.

Campo P et al., 2026: 2026 rat study in heterogeneous stock rats showing ivermectin reduced alcohol intake during acute withdrawal, with the effect tied to P2rx4 expression and GABAergic signalling in the central amygdala. Animal study, 131 male and female heterogeneous stock rats exposed to chronic intermittent ethanol vapour, United States; ivermectin administered to test withdrawal-driven self-administration. No human subjects. Declared: no known competing financial interests. This is the most recent preclinical extension of the alcohol claim and shows the hypothesis is still animal-only 14 years after the mouse work. Study type: animal.